Healthcare -
Biotechnology - NASDAQ - US
$ 5.01
5.92 %
$ 322 M
Market Cap
-5.06
P/E
CRVS - SHORT-TERM DEBT
Short-term Debt CRVS - Corvus Pharmaceuticals, Inc.
1.37 M
LAST VALUE
14.61%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR